FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care

Evidence-based recommendations on FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care.

Guidance development process

How we develop NICE diagnostics guidance

This guidance replaces NICE’s medtech innovation briefing on FibroScan for assessing liver fibrosis and cirrhosis in primary care (MIB216).